19 research outputs found
Recommended from our members
Recommendations in a heterogeneous service environment
This paper presents novel algorithms which are able to generate recommendations within a heterogeneous service environment. In this work explicitly set preferences as well as implicitly logged viewing behavior are employed to generate recommendations for Digital Video Broadcast (DVB) content. This paper also discusses the similarity between the DVB genres and YouTube categories. In addition it presents results to show the comparison between well known collaborative filtering methods. The outcome of this comparison study is used to identify the most suitable filtering method to use in the proposed environment. Finally the paper presents a novel Personal Program Guide (PPG), which is used as a tool to visualize the generated recommendations within a heterogeneous service environment. This PPG is also capable of showing the linear DVB content and the non-linear YouTube videos in a single view
The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy.
Item does not contain fulltextWe evaluated the efficacy of pregabalin in patients with chronic lumbosacral radiculopathy. This randomized, controlled, withdrawal trial included five phases: screening (4-18 days); run-in (4-10 days) to screen out placebo responders; single-blind (28 days) to identify pregabalin responders; double-blind to randomize responders to pregabalin or placebo (35 days); and final study medication taper (7 days). The primary endpoint was time to loss of response (LOR) during the double-blind phase (1-point increase in pain, discontinuation, or rescue-medication use). In the single-blind phase, 58% of patients had 30% pain reduction. In the double-blind phase, pregabalin (n=110) and placebo (n=107) groups did not differ significantly in time to LOR. Adverse events caused the discontinuation of 9.9% and 5.6% of pregabalin-treated and placebo-treated patients, respectively. Most patients with chronic lumbosacral radiculopathy responded to pregabalin therapy; however, time to LOR did not significantly differ between pregabalin and placebo. Considering the results of all phases of the study, it is difficult to draw definitive conclusions from it, suggesting a need for further work to understand the clinical potential of pregabalin treatment for lumbosacral radiculopathy.1 september 201